Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 520 clinical trials
Acute Heart Failure - COngestion Discharge Evaluation (AHF-CODE)

congestion assessed by implantable devices (not reimbursed in France) improves the prognosis. However, due to the lack of a standardised congestion assessment, therapeutic adaptation in acute heart failure

natriuretic peptide
congestion
pulmonary congestion
  • 0 views
  • 23 Mar, 2022
  • 1 location
Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation

> The main objective of the AHF-CODE study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are associated with the risk

  • 0 views
  • 30 Jan, 2021
  • 1 location
Acute Heart Failure With Preserved Ejection Fraction - COngestion Discharge Evaluation

. The main objective of the AHF-CODE preserved study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are

  • 12 views
  • 02 Feb, 2021
  • 1 location
Efficacy and Safety of Azeol Nasal Spray Versus Placebo in the Treatment of Early Symptoms of Common Cold in Adults

The main objective is to evaluate the efficacy of Azéol Spray Nasal, taken two times a day, versus placebo on nasal congestion in subject with common cold.

  • 0 views
  • 22 Dec, 2021
  • 1 location
A Nasal Spray for Relief of Nasal Congestion in Infants and Toddlers With Common Cold

The study will evaluate the safety and efficacy of the study medical device plus standard of care versus standard of care in subjects between 3 and 48 months (inclusive) presenting symptoms of a common cold.

Accepts healthy volunteers
  • 0 views
  • 30 May, 2022
  • 1 location
Research on Underlying Causes of Long-term Use of Nasal Decongestants and the Structured Withdrawal of the Decongestant

Rhinitis medicamentosa (RM) is a form of non-allergic medication-induced rhinitis characterised by nasal congestion. This nasal congestion is the result of the overuse of intranasal

Accepts healthy volunteers
  • 0 views
  • 02 Dec, 2021
  • 1 location
Splanchnic Nerve Block for Therapy of Chronic Heart Failure (Splanchnic III)

cardiac congestion in patients presenting with HF. Based on preliminary safety and efficacy data in acute and chronic heart failure patients with temporary (<24 h) SNB. Now we will apply a prolonged

  • 0 views
  • 30 Nov, 2021
  • 1 location
Fibrosis and the Fontan

the response to acute imposition of Fontan hemodynamics by examining the interrelationship between liver and cardiac fibrosis/dysfunction and lymphatic congestion along with a pilot trial of the

  • 0 views
  • 04 Jun, 2021
  • 1 location
Impella CP With VA ECMO for Cardiogenic Shock (REVERSE)

congestion, which can derail clinical improvement and hamper cardiac recovery. Indeed, percutaneous VA-ECMO increases LV afterload due to the retrograde blood flow, and because of the lack of venting, there

membrane oxygenation
myocardial infarction
inotropic agent
calcium
vasopressor
  • 10 views
  • 03 Mar, 2022
  • 1 location
LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients (AMBU-VAD)

signs of congestion or low cardiac output. Left ventricular assist devices (LVADs) have been used in patients with heart failure with reduced ejection fraction for almost 20 years either as an

  • 0 views
  • 06 Jun, 2022